Our findings demonstrate that use of 10 mg/day of monacolin K for 26 weeks significantly improved the plasma lipid profile, insulin sensitivity and biochemical steatosis scores in these patients, but it did not affect the body composition in terms of fat mass and visceral adipose tissue, nor liver elastographic characteristics. This evidence concerns the gene INS and steatosis.